ICON Public (NASDAQ:ICLR - Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided EPS guidance of 13.900-14.100 for the period, compared to the consensus EPS estimate of 13.970. The company issued revenue guidance of $8.3 billion-$8.3 billion, compared to the consensus revenue estimate of $8.3 billion. ICON Public also updated its FY 2025 guidance to 13.000-15.000 EPS.
Wall Street Analyst Weigh In
A number of brokerages recently commented on ICLR. Evercore ISI lowered their price objective on shares of ICON Public from $360.00 to $350.00 and set an "outperform" rating on the stock in a research report on Tuesday, October 8th. TD Cowen lowered their price target on shares of ICON Public from $369.00 to $285.00 and set a "buy" rating on the stock in a report on Friday, October 25th. StockNews.com lowered ICON Public from a "buy" rating to a "hold" rating in a report on Thursday, September 19th. Leerink Partners restated an "outperform" rating and issued a $255.00 target price (down previously from $270.00) on shares of ICON Public in a research note on Tuesday, November 19th. Finally, Royal Bank of Canada started coverage on ICON Public in a research note on Tuesday, January 7th. They set an "outperform" rating and a $263.00 price target for the company. Four equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $287.00.
Get Our Latest Stock Report on ICON Public
ICON Public Stock Performance
ICLR traded down $17.75 during trading on Tuesday, hitting $200.24. The stock had a trading volume of 1,830,683 shares, compared to its average volume of 899,485. The firm has a market cap of $16.52 billion, a PE ratio of 22.32, a P/E/G ratio of 1.54 and a beta of 1.20. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 0.35. ICON Public has a 12 month low of $183.38 and a 12 month high of $347.72. The company has a 50 day simple moving average of $211.31 and a 200-day simple moving average of $270.81.
ICON Public (NASDAQ:ICLR - Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The medical research company reported $3.35 EPS for the quarter, missing analysts' consensus estimates of $3.72 by ($0.37). ICON Public had a return on equity of 11.91% and a net margin of 9.00%. The business had revenue of $2.03 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the previous year, the firm posted $3.10 earnings per share. The company's revenue for the quarter was down 1.2% on a year-over-year basis. Analysts expect that ICON Public will post 13.42 EPS for the current year.
About ICON Public
(
Get Free Report)
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
See Also
Before you consider ICON Public, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICON Public wasn't on the list.
While ICON Public currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.